Navigation Links
Cytopia Letter to Progen Shareholders
Date:2/25/2009

li>Without partnering the merged entity would need to somehow raise another $95 million for this drug;
  • The HIV drug has failed to attract a partner and competition now includes new classes of HIV drugs (refer Bioshares article(1) www.cytopia.com.au/analyst.html)

    • Recommendation: Shareholders should vote against the Avexa merger by voting "NO" for ALL resolutions and, if not attending the meeting in person, should appoint Andrew Macdonald, the CEO of Cytopia, as their proxy.

    Please also advise Cytopia directly of this nomination by contacting the Company Secretary, Gavan Flower at the contact details below. A sample voting form is attached.

    The share buy-back resolution (Resolution 3) is conditional on the merger resolution (Resolution 1) being passed, and in any case, limits the share buy-back to $20 million. As the current Progen board is not supporting a share buy-back without the Avexa merger, we recommend you vote against all of the resolutions (including Resolution 3).

    At the 11 March 2009 meeting, we will put forward a motion to adjourn the meeting until immediately after the 27 March 2009 meeting. This will align the meetings, so that the Avexa merger and board replacement resolutions will be considered in conjunction with each other.

    Meeting on 27 March 2009

    Shareholders will have their opportunity to vote for a new board on 27 March 2009. The intent of the members calling the meeting was made clear in the members' statement - give all shareholders the choice of a share buy-back or staying as investors in an oncology company. A new board is needed to make this possible.

    Further material will be provided to shareholders closer to the meeting. In the meantime, we would be happy to answer any questions you may have
    '/>"/>

    SOURCE Cytopia Limited
    Copyright©2009 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5

    Related biology technology :

    1. Cytopia and Other Progen Shareholders Maintain Call for Meeting
    2. Presentation on Cytopias JAK2 Inhibitor Program in Myeloproliferative Disorders
    3. Cytopia Strengthens Scientific Team With US-Based Drug Development Specialist
    4. Cytopia Presentation on JAK2 Inhibitor at American Association for Cancer Research
    5. FDA Issues Complete Response Letter for RISPERDAL(R) CONSTA(R) for the Adjunctive Maintenance Treatment of Bipolar Disorder
    6. Shire Receives FOSRENOL Paragraph IV Notice Letters from Barr Laboratories and Mylan
    7. Corrected: XTL Biopharmaceuticals to Convene Extraordinary Shareholders Meetings after Receipt of Shareholder Letter
    8. XTL Biopharmaceuticals to Convene Extraordinary Shareholders Meetings after Receipt of Shareholder Letter
    9. Stanford writes in worlds smallest letters
    10. BioLife Solutions Launches BioPreservation Today(R) Industry Newsletter
    11. FDA Issues Complete Response Letter to SCOLR Pharmas Abbreviated New Drug Application for CDT(R) 12-Hour Pseudoephedrine

    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/24/2009)...ndpointhasbeenmetforpatientswithadvanced-stage,orr...4/PRNewswire-FirstCall/-AEternaZentarisInc.(NASDAQ...ticalcompanyfocusedonendocrinetherapyandoncology,t...ithitstargetedcytotoxicpeptideconjugate,AEZS-108(f...dometrialcancer.Inapersonalizedhealthcareapproach,...
    (Date:11/24/2009)...2009/PRNewswire-FirstCall/--ArenaPharmaceuticals,I...scheduledtopresentatthePiperJaffray21stAnnualHealt...ime(8:30a.m.PacificTime)attheNewYorkPalaceHotelinN...utiveOfficer,isscheduledtoprovideanoverviewoftheco...rograms. ,, Aliveaudiowebcastofthepresentationw...
    (Date:11/24/2009)... Program Connects Customers with Partners Validat...NA Genotek Products , Ott..., a leading provider of products for biological sa...day announced its new global partner program. The ...notek,s partner community and is designed to help ...
    (Date:11/23/2009)...23, 2009 In a provocative new study, a University...de emissions the major cause of global warming c...lapses or society builds the equivalent of one new...kely that there will be any substantial near-term ...arbon dioxide emission rates," says the new paper ...
    Breaking Biology Technology:AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4
    ...edarex, Inc. (Nasdaq: MEDX ) announced today tha... are expected to be the subject of poster presenta...ation for Cancer Research (AACR), being held April...ase I, open-label, dose-escalation, multi-dose stu...lonal antibody) in patients with CD30-positive ref...
    ... Magellan Biosciences, an emerging leader in syste...t & Sullivan 2009 North American Product Innov...e test that enables children and adults to be scre...onveniently. Magellan,s President of Clinical Diag...row night at the 2009 Excellence in Medical Techno...
    ...ch 17 The Healthcare and Science business of Th...nnual roundup of the "hottest" researchers and res...e Watch , Thomson Reuters identified the top 13 au...s in 2007-2008 as well as the most-cited research ...horing multiple Hot Papers serves to highlight res...
    Other Biology Technology:Medarex Announces Presentations at Annual Meeting of the American Association for Cancer Research 2Magellan to Receive Frost & Sullivan 2009 North American Product Innovation Award; Three-Minute LeadCare(R) II Test Identifies Children with Lead Poisoning 2Magellan to Receive Frost & Sullivan 2009 North American Product Innovation Award; Three-Minute LeadCare(R) II Test Identifies Children with Lead Poisoning 3Magellan to Receive Frost & Sullivan 2009 North American Product Innovation Award; Three-Minute LeadCare(R) II Test Identifies Children with Lead Poisoning 4Thomson Reuters Names 'Hottest' Researchers and Papers of 2007-2008 2
    (Date:11/23/2009)...on, D.C. The community-associated strain of the d...esistant to most common antibioticsposes a far gre...king its way into hospitals, according to a study ...ases . , The new threat is easily picked up in ...and has increased the overall burden of MRSA withi...
    (Date:11/23/2009)...study by the Wildlife Conservation Society says th...p in the Republic of Congopart of the "mother lode...arare becoming increasingly threatened by growing ...mends protection of the swamp forests adjacent to ...fter recent surveys confirmed that high densities ...
    (Date:11/23/2009)...IGN, Ill. A new study provides "incontrovertible ... on the island of Sumatra about 73,000 years ago d...from the epicenter, researchers report. , The vo... ash into the atmosphere, leaving a crater (now th...eters long and 35 kilometers wide. Ash from the ev...
    Breaking Biology News(10 mins):New study finds MRSA on the rise in hospital outpatients 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Global Gathering for Contact Center Professionals to Focus On Thinking Forward The Power of the Customer Experience at ICMIs Annual Call Center Exhi 56601 1Global Gathering for Contact Center Professionals to Focus On Thinking Forward The Power of the Customer Experience at ICMIs Annual Call Center Exhi 56601 2Global Gathering for Contact Center Professionals to Focus On Thinking Forward The Power of the Customer Experience at ICMIs Annual Call Center Exhi 56601 3Morrisey Associates Helps Healthcare Organizations Improve Patient Management Outside the Acute Care Setting 56599 1Morrisey Associates Helps Healthcare Organizations Improve Patient Management Outside the Acute Care Setting 56599 2Exotic Adventure and Clean Food 3A The Adventure Cookbook 56597 1Exotic Adventure and Clean Food 3A The Adventure Cookbook 56597 2
    ...ble biomedical devices that can act as artificial ...se paralyzed muscles to be moved might one day be ...ce. Writing today in Advanced Materials, Nicholas ...eagues describe how they have used hollow, submicr...nnect an integrated circuit to nerve cells. The ne...
    ...nd other "impotence drugs" that boost the producti...essels and produce an erection now also show promi...stem can recognize and attack them, say scientists...s at Hopkins on mice with implanted colon and brea...d threefold in sildenafil-treated animals, compare...
    ...omaviruses (HPV) are the most common sexually tran...in "high risk" types have been shown to cause cerv...tion and prevention of HPV, the link between the v...public. In June 2006, the Food and Drug Administr...infection of two high risk types of HPV, and two t...
    Other Biology News:Neural networking nanotubes 2'Erectile dysfunction' drugs heighten natural anti-cancer activity 2What does the public really know about HPV? 2What does the public really know about HPV? 3What does the public really know about HPV? 4
    6-Tube Magnetic Separation Rack from New England Biolabs
    ... at the 9, 10, 12, and 13 positions. It is intende...cation of 9(S)-HODE by GC- or LC-mass spectrometry...inoleic acid in both plants and animals. It has be...rified component of membrane phospholipids and in ...
    5(S)-HETE-d8, Deuterium Conjugated/Tagged from Cayman Chemical
    Silencer Validated siRNA - with sequence information 20 nmol from Ambion
    Biology Products: